Seeking Alpha

Depomed (DEPO) says that its lawsuits against two filers of Abbreviated New Drug Applications...

Depomed (DEPO) says that its lawsuits against two filers of Abbreviated New Drug Applications for Gralise have been dismissed at its own request. The dismissal was requested after Watson Laboratories (WPI) withdrew its application, and Par Pharmaceutical (PRX) amended its to no longer seek approval prior to the expiration of DEPO's Gralise patents listed for in the FDA's Orange Book.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)